These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22150373)

  • 1. Miliaria rubra and thrombocytosis in pseudohypoaldosteronism: case report.
    Onal H; Adal E; Ersen A; Onal Z; Keskindemirci G
    Platelets; 2012; 23(8):645-7. PubMed ID: 22150373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pustular miliaria rubra and systemic type 1b pseudohypoaldosteronism in a newborn].
    Argoubi H; Fitchner C; Richard O; Lavocat MP; Cambazard F; Stéphan JL
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 1):253-6. PubMed ID: 17389851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinico-pathological analysis of the cutaneous lesions of a patient with type I pseudohypoaldosteronism.
    Martín JM; Calduch L; Monteagudo C; Alonso V; García L; Jordá E
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):377-9. PubMed ID: 15857472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pustular miliaria rubra: a specific cutaneous finding of type I pseudohypoaldosteronism.
    Urbatsch A; Paller AS
    Pediatr Dermatol; 2002; 19(4):317-9. PubMed ID: 12220275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sweat glands in pseudohypoaldosteronism].
    Aberer E; Gebhart W; Mainitz M; Pollak A; Reichel G; Scheibenreiter S
    Hautarzt; 1987 Aug; 38(8):484-7. PubMed ID: 3654220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn with pseudohypoaldosteronism and miliaria rubra.
    Akcakus M; Koklu E; Poyrazoglu H; Kurtoglu S
    Int J Dermatol; 2006 Dec; 45(12):1432-4. PubMed ID: 17184247
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I.
    Geller DS; Rodriguez-Soriano J; Vallo Boado A; Schifter S; Bayer M; Chang SS; Lifton RP
    Nat Genet; 1998 Jul; 19(3):279-81. PubMed ID: 9662404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.
    Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic disorders caused by gain or loss of function of the mineralocorticoid receptor].
    Arai K; Shibasaki T
    Nihon Rinsho; 2002 Feb; 60(2):361-6. PubMed ID: 11857927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudohypoaldosteronism.
    Riepe FG
    Endocr Dev; 2013; 24():86-95. PubMed ID: 23392097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudohypoaldosteronisms, report on a 10-patient series.
    Belot A; Ranchin B; Fichtner C; Pujo L; Rossier BC; Liutkus A; Morlat C; Nicolino M; Zennaro MC; Cochat P
    Nephrol Dial Transplant; 2008 May; 23(5):1636-41. PubMed ID: 18424465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel SCNN1A gene splicing-site mutation causing autosomal recessive pseudohypoaldosteronism type 1 (PHA1) in two Italian patients belonging to the same small town.
    Serra G; Antona V; D'Alessandro MM; Maggio MC; Verde V; Corsello G
    Ital J Pediatr; 2021 Jun; 47(1):138. PubMed ID: 34134742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular features of type 1 pseudohypoaldosteronism.
    Riepe FG
    Horm Res; 2009; 72(1):1-9. PubMed ID: 19571553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.
    Pujo L; Fagart J; Gary F; Papadimitriou DT; Claës A; Jeunemaître X; Zennaro MC
    Hum Mutat; 2007 Jan; 28(1):33-40. PubMed ID: 16972228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exclusion of serum- and glucocorticoid-induced kinase 1 (SGK1) as a candidate gene for genetically heterogeneous renal pseudohypoaldosteronism type I in eight families.
    Riepe FG; Holterhus PM
    Am J Nephrol; 2007; 27(2):164-9. PubMed ID: 17317952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic pseudohypoaldosteronism-1 with episodic dyslipidemia in a Sudanese child.
    Abdalla A; Alhassan MA; Tawfeeg R; Sanad A; Tawamie H; Abdullah M
    Endocrinol Diabetes Metab Case Rep; 2021 Jun; 2021():. PubMed ID: 34165441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mineralocorticoid resistance: pseudohypoaldosteronism type 1].
    Fernandes-Rosa FL; Antonini SR
    Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):373-81. PubMed ID: 17546235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of pseudohypoaldosteronism type 1 with a mutation in the mineralocorticoid receptor gene.
    Lee SE; Jung YH; Han KH; Lee HK; Kang HG; Ha IS; Choi Y; Cheong HI
    Korean J Pediatr; 2011 Feb; 54(2):90-3. PubMed ID: 21503203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudohypoaldosteronism due to sweat gland dysfunction.
    Anand SK; Froberg L; Northway JD; Weinberger M; Wright JC
    Pediatr Res; 1976 Jul; 10(7):677-82. PubMed ID: 934733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and molecular basis of pseudohypoaldosteronism type 1.
    Tajima T; Morikawa S; Nakamura A
    Clin Pediatr Endocrinol; 2017; 26(3):109-117. PubMed ID: 28804203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.